findmyKOL

Shahzaib Nabi, MD

Basic profile

Brooklyn Hospital Center

ORCIDNPI
RegionBrooklyn, NY · NortheastSpecialtyHematology / OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Shahzaib Nabi is an Oncology physician affiliated with Brooklyn Hospital Center. OpenAlex indexes 36 publications with 263 citations (h-index 7).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
36publications

Distinct works indexed by OpenAlex, matched via ORCID.

263citations

Total citations across indexed works.

7h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
14companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

447 Atlantic Ave
Brooklyn, NY 112171702

Telephone

718-732-4080

Provider last certified this registry record 8 Jan 2026.

View the NPPES registry record

Industry payments

14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    40.6%
    Aromatase Inhibitor13.4%
    Anastrozole60%Letrozole31%Exemestane9%
    Part D<11 patients
    Kinase inhibitor5.8%
    Ibrance35%Verzenio33%Imbruvica17%Lenvima16%
    Part D<11 patients

    + 9 more classes in this area

  • Blood & clotting

    26%
    Factor Xa inhibitor15.5%
    Eliquis68%Xarelto32%
    Part D23 patients
    Solutions for parenteral nutrition8.2%
    Calcium Acetate100%
    Part D19 patients

    + 1 more class in this area

  • Nervous system

    15.4%
    Other antidepressants8.4%
    Mirtazapine100%
    Part D43 patients
    Gabapentinoids4.5%
    Gabapentin54%Pregabalin46%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)21.6% facility · 78.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”